Back to all news and events

3 April 2018

Meditrial Europe awarded ISO 9001:2015 Certification

Meditrial Europe is one of the first and few CROs awarded ISO 9001:2015 certification, confirming its leadership in clinical research and digital solutions for the medical device industry.

Read more

Nov 23 - 24, 2017

HeartLab 2017 – Zurich

Meet us in Zurich, Switzerland

Read more

30 October 2017

HighLife closes €12.3 million financing round led by Sofinnova Partners

This financing allows for the acceleration of the company’s clinical and R&D program

Read more

11 October 2017

BioVentrix Announces First Patient Enrolled in the U.S. arm of IDE Study of the Revivent TC™ TransCatheter Ventricular Enhancement Treatment

The trial is designed to demonstrate the safety and effectiveness of the Revivent TC™ TransCatheter Ventricular Enhancement System

Read more

5 October 2017

CARMAT expands its PIVOTAL study internationally, in line with its clinical strategy and CE marking process

Approval granted to perform implants in Kazakhstan, leading country in heart device trials for the European market

Read more

2 October 2017

Boston Scientific Announces Agreement to Acquire Apama Medical

Acquisition to Strengthen Company’s Electrophysiology Portfolio and Expand into “Single-Shot” Balloon Pulmonary Vein Isolation Treatments for Patients with Atrial Fibrillation

Read more

1 September 2017

CardiAQ Valve Tech vs Neovasc : Ruling from Appeals Court on TIARA patent family

Appeal Court upholds lower court decisions but denies injunction

Read more

April 27-28, 2017

AATS Mitral Conclave

Meet us in New York, US

Read more

15 March 2017

New AHA/ACC guideline on valvular heart disease management

On March 15, 2017 the AHA/ACC have released a focused update of guidelines for the treatment of patients with valvular heart disease.

Read more

13 March 2017

European council unanimously adopts MDR and IVDR, introducing deep changes in world’s second-largest device market.

The European Union new rules governing medical device and in vitro diagnostics (IVDs) are one step away from final approval.

Read more